October 02, 2025 10:00 ET | Source: Cirrus Therapeutics, Inc. Cirrus’ lead program is a novel AAV gene therapy designed…
Backed by global leaders in aviation, energy, and climate investing, OXCCU strengthens its position as a critical player in the global…
DUISBURG, Germany, Sept. 19, 2025 /PRNewswire/ -- Factor2 Energy, a German (Duisburg) company with a novel approach to geothermal energy, today…
PANAMA CITY, Sept. 19, 2025 /PRNewswire/ -- Grvt, the preeminent DEX (decentralized exchange) for onchain financial privacy that is powered…
NEW YORK and LONDON and BUCHAREST, Romania, Sept. 17, 2025 /PRNewswire/ -- DRUID AI today announced it has secured $31 million in…
NEW YORK, Sept. 10, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…
Social Leverage backs LEA’s mission to eliminate manual document work and quickly deliver clean data to core systems firms rely…
NEW YORK, Sept. 4, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…
New investors NEA and SR One lead round alongside existing investors OrbiMed, F-Prime, NVIDIA and Khosla VenturesCHARM’s AI-designed menin inhibitor…
ZUG, Switzerland, Sept. 1, 2025 /PRNewswire/ -- Berlin Heals Holding AG, a MedTech company, is developing a novel treatment to…